VCs in $47m round for Chinese AI medical imaging firm
Beijing Infervision, a Chinese company that develops medical imaging technology empowered by artificial intelligence (AI), has raised RMB300 million ($47 million) in funding from investors including Xianghe Capital.
Advantech Capital, Genesis Capital, Sequoia Capital China and Qiming Venture Partners also participated. The company has earmarked the proceeds for commercialization and clinical trials of its products,...
More on Greater China
Latest News
Profile: MSA Capital’s Jenny Zeng
Having participated in Chinese private equity as GP, LP, advisor, and industry association executive, Jenny Zeng has clear ideas as to what makes a good founder. These are being put into practice at MSA Capital
Deal focus: Carlyle targets consumerism in ceramics
The Carlyle Group, like many investors, sees premiumisation as a natural outcome of the expansion of India’s middle class. It could be the first to test this thesis in the local building materials industry
Deal focus: India’s Shubham sees opening to accelerate
Shubham believes its long-curated datasets and institutional memory differentiate it from a growing pack of low-income housing lenders. Global impact investors appear convinced